Opportunity ID: 270250

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-15-021
Funding Opportunity Title: Testing Multi-Level Interventions to Improve Blood Pressure Control in Minority Racial/Ethnic, Low Socioeconomic Status, and/or Rural Populations (UH2/UH3)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.837 — Cardiovascular Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 08, 2014
Last Updated Date: Jan 27, 2015
Original Closing Date for Applications: Feb 13, 2015
Current Closing Date for Applications: Feb 19, 2015
Archive Date: Mar 19, 2015
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Small businesses
Special district governments
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
For profit organizations other than small businesses
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) solicits applications to fund up to two patient-centered comparative effectiveness clinical trials using a UH2/UH3 cooperative agreement mechanism. This initiative is supported by the Hypertension Disparities Reduction Program Partnership (HDRPP), a research partnership between NHLBI, NINDS, and the Patient-Centered Outcomes Research Institute (PCORI), with funds provided by PCORI to the NIH. The research initiative aims to reduce disparities in hypertension, a leading cause of cardiovascular disease that disproportionately affects certain populations including racial and ethnic minorities, individuals with low socioeconomic status, and rural communities. Approximately 30% of adults in the U.S. have hypertension, and of these, more than half have uncontrolled hypertension. The purpose of the FOA is to compare alternative, evidence-based approaches to reduce inadequate control of hypertension among high risk populations, including racial/ethnic minority groups, patients with low socioeconomic status (SES), and individuals residing in rural geographical areas with an above average lifetime risk of cardiovascular disease (CVD).
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-021.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Modified to update the close date field, in accordance with the NIH Guide NOT-OD-15-057. Jan 27, 2015
Jan 27, 2015

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-15-021
Funding Opportunity Title: Testing Multi-Level Interventions to Improve Blood Pressure Control in Minority Racial/Ethnic, Low Socioeconomic Status, and/or Rural Populations (UH2/UH3)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.837 — Cardiovascular Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 08, 2014
Last Updated Date: Jan 27, 2015
Original Closing Date for Applications: Feb 13, 2015
Current Closing Date for Applications: Feb 19, 2015
Archive Date: Mar 19, 2015
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Small businesses
Special district governments
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
For profit organizations other than small businesses
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) solicits applications to fund up to two patient-centered comparative effectiveness clinical trials using a UH2/UH3 cooperative agreement mechanism. This initiative is supported by the Hypertension Disparities Reduction Program Partnership (HDRPP), a research partnership between NHLBI, NINDS, and the Patient-Centered Outcomes Research Institute (PCORI), with funds provided by PCORI to the NIH. The research initiative aims to reduce disparities in hypertension, a leading cause of cardiovascular disease that disproportionately affects certain populations including racial and ethnic minorities, individuals with low socioeconomic status, and rural communities. Approximately 30% of adults in the U.S. have hypertension, and of these, more than half have uncontrolled hypertension. The purpose of the FOA is to compare alternative, evidence-based approaches to reduce inadequate control of hypertension among high risk populations, including racial/ethnic minority groups, patients with low socioeconomic status (SES), and individuals residing in rural geographical areas with an above average lifetime risk of cardiovascular disease (CVD).
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-021.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-15-021
Funding Opportunity Title: Testing Multi-Level Interventions to Improve Blood Pressure Control in Minority Racial/Ethnic, Low Socioeconomic Status, and/or Rural Populations (UH2/UH3)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.837 — Cardiovascular Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 27, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Feb 13, 2015
Archive Date: Mar 16, 2015
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
City or township governments
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
For profit organizations other than small businesses
State governments
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
Private institutions of higher education
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) solicits applications to fund up to two patient-centered comparative effectiveness clinical trials using a UH2/UH3 cooperative agreement mechanism. This initiative is supported by the Hypertension Disparities Reduction Program Partnership (HDRPP), a research partnership between NHLBI, NINDS, and the Patient-Centered Outcomes Research Institute (PCORI), with funds provided by PCORI to the NIH. The research initiative aims to reduce disparities in hypertension, a leading cause of cardiovascular disease that disproportionately affects certain populations including racial and ethnic minorities, individuals with low socioeconomic status, and rural communities. Approximately 30% of adults in the U.S. have hypertension, and of these, more than half have uncontrolled hypertension. The purpose of the FOA is to compare alternative, evidence-based approaches to reduce inadequate control of hypertension among high risk populations, including racial/ethnic minority groups, patients with low socioeconomic status (SES), and individuals residing in rural geographical areas with an above average lifetime risk of cardiovascular disease (CVD).
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-021.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00210531 Jan 13, 2015 Feb 19, 2015 View

Package 1

Mandatory forms

270250 RR_SF424_2_0-2.0.pdf

270250 PHS398_ResearchPlan_2_0-2.0.pdf

270250 PHS398_CoverPageSupplement_2_0-2.0.pdf

270250 RR_Budget_1_3-1.3.pdf

270250 RR_KeyPersonExpanded_2_0-2.0.pdf

270250 RR_OtherProjectInfo_1_3-1.3.pdf

270250 PerformanceSite_2_0-2.0.pdf

Optional forms

270250 PlannedReport-1.0.pdf

270250 PHS398_CumulativeInclusionReport-1.0.pdf

270250 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-09T20:49:13-05:00

Share This Post, Choose Your Platform!

About the Author: